63009-94-9 Usage
Type of Drug
Synthetic stimulant
Effect on the Body
Affects the central nervous system
Addiction Potential
Highly addictive
Health Risks
Can lead to severe health issues and addiction
Manufacturing
Typically manufactured in illegal laboratories
Abuse
Commonly abused for its euphoric effects
Physical Symptoms
Can cause increased heart rate, elevated blood pressure, and insomnia
Long-term Effects
Chronic use can lead to long-term damage to the brain and body, as well as a range of mental health issues
Legal Classification
Classified as a Schedule II drug by the United States Drug Enforcement Administration
Abuse and Dependence
Has a high potential for abuse and dependence
Check Digit Verification of cas no
The CAS Registry Mumber 63009-94-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,0,0 and 9 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 63009-94:
(7*6)+(6*3)+(5*0)+(4*0)+(3*9)+(2*9)+(1*4)=109
109 % 10 = 9
So 63009-94-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H15NO/c1-11-8-10(12)7-9-5-3-2-4-6-9/h2-6,10-12H,7-8H2,1H3
63009-94-9Relevant academic research and scientific papers
Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith
-
Page/Page column 31, (2008/12/07)
Provided herein are Heterocyclic Compounds having the following structure: wherein R1, R2, X, Y and Z are as defined herein, compositions comprising an effective amount of a Heterocyclic Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heterocyclic Compound to a patient in need thereof.
INHIBITORS OF Akt ACTIVITY
-
Page/Page column 136, (2010/11/27)
Invented are novel thiophene compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
Pyridoquinoxaline antivirals
-
, (2008/06/13)
The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof wherein R1, R2 and R3 are as defined in the specification. The compounds are useful for the treatment of viral infections.
